Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

Anaemia commonly occurs in cancer patients receiving chemotherapy, often necessitating blood transfusion. This multicentre study was designed to evaluate the efficacy and safety of epoetin α in preventing the decline in haemoglobin (Hb) level, and to determine whether the transfusion requirement cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Thatcher, N, Campos, E S De, Bell, D R, Steward, W P, Varghese, G, Morant, R, Vansteenkiste, J F, Rosso, R, Ewers, S-B, Sundal, E, Schatzmann, E, Stocker, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362337/
https://www.ncbi.nlm.nih.gov/pubmed/10408844
http://dx.doi.org/10.1038/sj.bjc.6690369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362337/
https://www.ncbi.nlm.nih.gov/pubmed/10408844
http://dx.doi.org/10.1038/sj.bjc.6690369

Ejemplares similares